Wu K - Search Results

1

COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.

Zheng L, Deng CL, Wang L, Huang XB, You N, Tang YC, Wu K, Liang P, Mi N, Li J. Zheng L, et al. Among authors: wu k. Oncotarget. 2016 May 31;7(22):32774-84. doi: 10.18632/oncotarget.9047. Oncotarget. 2016. PMID: 27129158 Free PMC article.

2

COMMD7 activates CXCL10 production by regulating NF-κB and the production of reactive oxygen species.

You N, Li J, Huang X, Wu K, Tang Y, Wang L, Li H, Mi N, Zheng L. You N, et al. Among authors: wu k. Mol Med Rep. 2018 May;17(5):6784-6788. doi: 10.3892/mmr.2018.8706. Epub 2018 Mar 8. Mol Med Rep. 2018. PMID: 29532873

3

COMMD7 Regulates NF-κB Signaling Pathway in Hepatocellular Carcinoma Stem-like Cells.

Zheng L, You N, Huang X, Gu H, Wu K, Mi N, Li J. Zheng L, et al. Among authors: wu k. Mol Ther Oncolytics. 2018 Dec 14;12:112-123. doi: 10.1016/j.omto.2018.12.006. eCollection 2019 Mar 29. Mol Ther Oncolytics. 2018. PMID: 30719501 Free PMC article.

4

COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.

You N, Li J, Gong Z, Huang X, Wang W, Wang L, Wu K, Zheng L. You N, et al. Among authors: wu k. Mol Carcinog. 2017 Feb;56(2):607-624. doi: 10.1002/mc.22520. Epub 2016 Jul 8. Mol Carcinog. 2017. PMID: 27350032

5

COMMD7 promotes hepatocellular carcinoma through regulating CXCL10.

You N, Li J, Huang X, Wu K, Tang Y, Wang L, Li H, Mi N, Zheng L. You N, et al. Among authors: wu k. Biomed Pharmacother. 2017 Apr;88:653-657. doi: 10.1016/j.biopha.2017.01.046. Epub 2017 Jan 29. Biomed Pharmacother. 2017. PMID: 28142122

6

Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.

You N, Tan Y, Zhou L, Huang X, Wang W, Wang L, Wu K, Mi N, Li J, Zheng L. You N, et al. Among authors: wu k. Exp Cell Res. 2017 Sep 15;358(2):217-226. doi: 10.1016/j.yexcr.2017.06.021. Epub 2017 Jun 27. Exp Cell Res. 2017. PMID: 28663060

7

Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma.

Gu H, Li J, You N, Wu K, Wang Z, Wang L, Zhu Y, Liu Q, Peng X, Zheng L. Gu H, et al. Among authors: wu k. Ann Transl Med. 2020 Dec;8(24):1677. doi: 10.21037/atm-20-7244. Ann Transl Med. 2020. PMID: 33490189 Free PMC article.

8

Camrelizumab Plus Sorafenib Versus Sorafenib Monotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Analysis.

Liu Q, You N, Li J, Wu K, Peng X, Wang Z, Wang L, Zhu Y, Zheng L. Liu Q, et al. Among authors: wu k. Front Oncol. 2021 Oct 19;11:694409. doi: 10.3389/fonc.2021.694409. eCollection 2021. Front Oncol. 2021. PMID: 34737945 Free PMC article.

9

Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients.

Wu K, You N, Zheng L. Wu K, et al. J Gastrointest Oncol. 2021 Dec;12(6):2999-3007. doi: 10.21037/jgo-21-792. J Gastrointest Oncol. 2021. PMID: 35070425 Free PMC article.

10

Laparoscopic liver resection of segment 8 via a hepatic parenchymal transection-first approach guided by the middle hepatic vein.

You N, Wu K, Li J, Zheng L. You N, et al. Among authors: wu k. BMC Gastroenterol. 2022 May 8;22(1):224. doi: 10.1186/s12876-022-02289-8. BMC Gastroenterol. 2022. PMID: 35527252 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,763 results

Search Page

Filters